Publications by authors named "Quentin Lecrevisse"

The clinical manifestation of COVID-19 after SARS-CoV-2 infection varies greatly, with many patients requiring intensive care due to complications like acute respiratory distress syndrome, reduced respiratory system compliance, and altered iron metabolism, which can be mistaken for worsening Influenza A infection. This highlights the need to study the humoral immune response to better understand the pathophysiology of viral respiratory infections and improve treatments and diagnostics. This study analyzed autoantibody and acute-phase reactant profiles in patients infected with SARS-CoV-2 and Influenza A using customized protein microarrays for sensitive and reproducible results.

View Article and Find Full Text PDF

T-cell chronic lymphoproliferative disorders (T-CLPD) are a heterogeneous group of mature T-cell malignancies, the classification of which remains challenging. In this study, we classified tumor cells from 86 patients diagnosed with either T-CLPD (n = 81) or T-cell acute lymphoblastic leukemia (n = 5) into precise functional and maturation-associated compartments, based on their phenotypic similarities with their normal maturation-related and functional associated T-cell counterparts. A database was generated using blood samples from 6 sex- and age-matched healthy donors as a template for normal T-cell subset flow cytometric immunophenotypes, to which tumor cells of individual patients were compared.

View Article and Find Full Text PDF

Introduction: The interactions between T-cell chronic lymphoproliferative disorder (T-CLPD) tumor cells and the bystander immune cells may play a critical role in the failure of immune surveillance and disease progression, but the altered blood immune profiles of T-CLPD remain unknown.

Methods: Here we analyzed the distribution of residual non-tumoral immune cells in blood of 47 T-CLPD patients -14 T-prolymphocytic leukemia (T-PLL), 7 Sézary syndrome/mycosis fungoides (SS/MF) and 26 T-large granular lymphocytic leukemia (T-LGLL)-, as tumor models of neoplastic T-cells that resemble naive/central memory (N/CM), memory and terminal effector T-cells, respectively, compared to 110 age- and sex-matched healthy donors, using spectral flow cytometry.

Results: Overall, our results showed deeply altered immune cell profiles in T-PLL, characterized by significantly increased counts of monocytes, dendritic cells, B-cells, NK-cells and innate lymphoid cells (ILC) -particularly ILC3-, together with reduced normal T-cells.

View Article and Find Full Text PDF

The early immune kinetics after SARS-CoV-2 vaccination remain poorly understood, particularly among individuals with low-count monoclonal B-cell lymphocytosis (MBL). We investigated the cellular and humoral kinetics in the blood of 50 non-MBL healthy donors (HD) vs. 16 MBL subjects after SARS-CoV-2 vaccination, who were subclassified according to their history of previous exposure to SARS-CoV-2 into SARS-CoV-2 naïve and previously infected subjects.

View Article and Find Full Text PDF

In the past decade, a major goal in biomedical research has been to understand why individuals differ in disease susceptibility, disease dynamics, and progression. In many pathologies, this variability stems from evolved immune mechanisms that resist inflammatory stress from various diseases that have been encountered throughout life. These may provide advantages against other diseases, reduce comorbidities, and enhance longevity.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic mastocytosis (SM) is a complex disease linked to abnormal mast cells that release mediators affecting the immune environment.
  • The study aimed to explore the blood profiles of B-cells, plasma cells, and antibody types in 108 SM patients compared to healthy individuals.
  • Results showed increased immature B-cells and elevated IgM and IgD levels in SM patients, alongside decreased plasma cells across various IgH types, with unique immune patterns based on the SM subtype.
View Article and Find Full Text PDF

Immunopeptidomics is the area of knowledge focused on the study of peptides assembled in the major histocompatibility complex (MHC), or human leukocyte antigen (HLA) in humans, which could activate the immune response via specific and selective T cell recognition. Advances in high-sensitivity mass spectrometry have enabled the detailed identification and quantification of the immunopeptidome, significantly impacting fields like oncology, infections, and autoimmune diseases. Current immunopeptidomics approaches primarily focus on workflows to identify immunopeptides from HLA molecules, requiring the isolation of the HLA from relevant cells or tissues.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic mastocytosis (SM) is a complex disease marked by an increase in abnormal mast cells that can affect the immune system and tumor environment.
  • Researchers analyzed blood samples from 115 SM patients and 83 healthy individuals to assess the distribution of various immune cells and their relationship with disease characteristics.
  • Findings indicated that SM patients had reduced levels of specific immune cell types compared to healthy controls, with these variations depending on the subtype of SM and certain genetic factors linked to the disease.
View Article and Find Full Text PDF

Monoclonal gammopathy of undetermined significance (MGUS) is the earliest discernible stage of multiple myeloma (MM) and Waldenström's macroglobulinemia (WM). Early diagnosis of MG may be compromised by the low-level infiltration, undetectable to low-sensitive methodologies. Here, we investigated the prevalence and immunophenotypic profile of clonal (c) plasma cells (PC) and/or cB-lymphocytes in bone marrow (BM) and blood of subjects with a serum M-component from the iSTOPMM program, using high-sensitive next-generation flow cytometry (NGF), and its utility in the diagnostic classification of early-stage MG.

View Article and Find Full Text PDF
Article Synopsis
  • Low-count monoclonal B-cell lymphocytosis (MBL) is linked to a higher risk of severe COVID-19 and potential immunodeficiency.
  • A study involving 336 COVID-19 patients showed that MBL patients had increased counts of certain immune cells, especially plasma cells, but decreased counts of others like lymphocytes, particularly in the early stages of infection.
  • MBL patients also exhibited a delayed but stronger antibody response compared to non-MBL patients, indicating distinct immune responses in the context of COVID-19.
View Article and Find Full Text PDF
Article Synopsis
  • - Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Western countries and is linked to specific immune responses involving autoantigens and microbial proteins.
  • - The study analyzed serum levels of 7 immunoglobulins in patients with CLL and monoclonal B-cell lymphocytosis, revealing notable changes in IgA and IgG that corresponded to disease progression and genetic factors.
  • - Findings suggest that variations in serum immunoglobulin levels could serve as biomarkers for CLL progression, with specific autoantibodies and responses to microbes indicating potential prognostic indicators for the disease.
View Article and Find Full Text PDF
Article Synopsis
  • * Diagnosis can be made through the presence of specific B lymphocytes in the blood, and various prognostic indicators, like genetic mutations, can affect outcomes.
  • * A study profiled 103 proteins in CLL and monoclonal B-cell lymphocytosis (MBL) samples, finding unique immune factors that differentiate between the two conditions and could serve as potential biomarkers for understanding CLL's immune landscape and treatment responses.
View Article and Find Full Text PDF
Article Synopsis
  • Acute phase reactants (APRs) are important for understanding inflammation, but their varying levels make it challenging to measure them together in clinical settings.
  • A new multiplex assay has been developed to enable high-throughput and simultaneous detection of APRs, improving accuracy in measuring their levels.
  • This research, using Sars-CoV-2 as a model, identified different APR patterns between healthy and infected individuals, suggesting that these profiles could help in diagnosing and managing the severity of conditions like respiratory distress and sepsis.
View Article and Find Full Text PDF

Acute respiratory distress syndrome (ARDS) is a severe pulmonary disease, which is one of the major complications in COVID-19 patients. Dysregulation of the immune system and imbalances in cytokine release and immune cell activation are involved in SARS-CoV-2 infection. Here, the inflammatory, antigen, and auto-immune profile of patients presenting COVID-19-associated severe ARDS has been analyzed using functional proteomics approaches.

View Article and Find Full Text PDF

In the present work, leptomeningeal disease, a very destructive form of systemic cancer, was characterized from several proteomics points of view. This pathology involves the invasion of the leptomeninges by malignant tumor cells. The tumor spreads to the central nervous system through the cerebrospinal fluid (CSF) and has a very grim prognosis; the average life expectancy of patients who suffer it does not exceed 3 months.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied 139 healthcare workers with past SARS-CoV-2 infections to investigate heart complications like pericarditis and myocarditis.
  • The study found that 30.9% of participants exhibited signs of heart inflammation, with various immune cell abnormalities noted, including decreased eosinophils and increased cytotoxic T cells.
  • Despite clinical stability, a significant number of participants experienced symptoms and abnormal results in tests like electrocardiograms and cardiac MRI, suggesting ongoing cardiac issues post-infection.*
View Article and Find Full Text PDF

Human Proteome Project (HPP) presents a systematic characterization of the protein landscape under different conditions using several complementary-omic techniques (LC-MS/MS proteomics, affinity proteomics, transcriptomics, etc.). In the present study, using a B-cell lymphoma cell line as a model, comprehensive integration of RNA-Seq transcriptomics, MS/MS, and antibody-based affinity proteomics (combined with size-exclusion chromatography) (SEC-MAP) were performed to uncover correlations that could provide insights into protein dynamics at the intracellular level.

View Article and Find Full Text PDF

Introduction And Objectives: The cardiac sequelae of SARS-CoV-2 infection are still poorly documented. We conducted a cross-sectional study in healthcare workers to report evidence of pericardial and myocardial involvement after SARS-CoV-2 infection.

Methods: We studied 139 healthcare workers with confirmed past SARS-CoV-2 infection.

View Article and Find Full Text PDF

Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between mature B-cell neoplasms are lacking. We developed an algorithm-driven classification for these lymphomas by flow cytometry and compared it to the WHO gold standard diagnosis. Overall, 662 samples from 662 patients representing 9 disease categories were analyzed at 9 laboratories using the previously published EuroFlow 5-tube-8-color B-cell chronic lymphoproliferative disease antibody panel.

View Article and Find Full Text PDF

Sporadic Colorectal Cancer (sCRC) is the third leading cause of cancer death in the Western world, and the sCRC patients presenting with synchronic metastasis have the poorest prognosis. Genetic alterations accumulated in sCRC tumor cells translate into mutated proteins and/or abnormal protein expression levels, which contribute to the development of sCRC. Then, the tumor-associated proteins (TAAs) might induce the production of auto-antibodies (aAb) via humoral immune response.

View Article and Find Full Text PDF